PwC MoneyTree is the go-to source for Venture Capital firms and high-growth startups.
The PwC MoneyTree website is home to the PwC/CB Insights quarterly MoneyTree Report. It contains historical trend data beginning with 1995, updates on the Venture Capital and high-growth startups ecosystem, and relevant insights from PwC’s emerging company services and venture capital tax, audit and advisory professionals. The PwC/CB Insights MoneyTree Report is the definitive source of information on venture capital investments in emerging companies. This study is a staple of the financial community, entrepreneurs, government policymakers and the business press worldwide.
While funding to VC-backed companies in the United States increased 4%, reaching $21.1B invested across 1,206 deals, deal activity declined 2%. A high number of mega-rounds contributed to the funding growth this quarter, which was the second-consecutive quarter with over 30 rounds of $100M or more. Q1’18 saw 34 mega-rounds to US VC-backed companies, which accounted for 34% of total funding, but down from 42% in Q4’17. This marks the first decline since Q4’16.
PwC and CB Insights' Healthcare MoneyTree report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.
2018 looks to continue the trend of larger deals as we’ve now seen two consecutive quarters with over 30 rounds of $100M or more – only the second time in recent history that this has happened. Additionally, the $21B we saw invested this quarter is a record high, just the second time we’ve reached this funding level during the last 15 years, and Artificial Intelligence saw its biggest funding quarter ever (over $1.8B).
Partner, US Pharmaceuticals and Life Sciences , PwC US
Tel: +1 (408) 817 5029